Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.

Molecular diagnosis & therapy - 1 Apr 2014

Schlaf Gerald, Pollok-Kopp Beatrix, Altermann Wolfgang W

Abstract excerpt

Transplant recipients who have had sensitizing events such as pregnancies, blood transfusions and previous transplants often develop antibodies directed against human leukocyte antigen (HLA)-molecules of the donor tissue. These pre-formed donor-specific antibodies (DSA) represent a high risk of organ failure as a consequence of antibody-mediated hyper-acute or acute allograft rejection. As a first assay to detect...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Allografts
Share to Antibody Specificity
Share to Enzyme-Linked Immunosorbent Assay

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to Graft Rejection

Share to Graft Survival

Share to HLA Antigens

Share to Phenotype

Source

Identifiers

PMID: 24170304
DOI: 10.1007/s40291-013-0063-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.PMID 24170304Read ↗

Review article: Luminex technology for HLA antibody detection in organ transplantation.Semantic proximity Read ↗

Systematic Comparison of Four Cell- and Luminex-Based Methods for Assessment of Complement-Activating HLA AntibodiesSemantic proximity Read ↗

The good, the bad, and the ugly of luminex donor-specific crossmatch.Semantic proximity Read ↗

Determination of unacceptable HLA antigen mismatches in kidney transplant recipients.Semantic proximity Read ↗

Clinical relevance of donor-specific antibodies directed at HLA-C: A long road to acceptance.Semantic proximity Read ↗

An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLASemantic proximity Read ↗

Phenotypes of antibody-mediated rejection in organ transplants.Semantic proximity Read ↗

Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury.Semantic proximity Read ↗

C3d-binding assay for the detection of complement activating HLA antibodies: A useful tool for allocation to highly sensitised recipients in the post-CDC era?Semantic proximity Read ↗

HLA antibody affinity determination: From HLA-specific monoclonal antibodies to donor HLA specific antibodies (DSA) in patient serum.Semantic proximity Read ↗

Evaluation of a new complement-dependent lymphocytotoxicity cross match method using an automated cell counter, the NucleoCounter® NC-3000™.Semantic proximity Read ↗

Donor specific antibodies after transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.